
Intensive blood-pressure lowering after stroke reperfusion probably increased mortality without meaningful functional benefit
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A Cochrane review of nine randomized trials involving 4,381 adults found that intensive systolic targets below 160 mmHg after ischemic-stroke reperfusion produced no clinically meaningful functional or hemorrhage benefit and probably increased all-cause mortality.
What NurseJet pulled from the source
This Cochrane review compared intensive systolic blood-pressure targets below 160 mmHg with conventional targets, generally below 180 mmHg, after thrombolysis or endovascular thrombectomy for ischemic stroke. Nine randomized trials included 4,381 participants. Intensive management produced little to no clinically meaningful difference in functional outcomes and did not change the risk of any intracranial hemorrhage (RR 0.99, 95% CI 0.87 to 1.14). It probably increased all-cause mortality (RR 1.19, 95% CI 1.08 to 1.32) and probably reduced the proportion of participants with favorable neurologic status, although the estimate included the possibility of little difference. The review does not support assuming that a lower post-reperfusion target is safer or more effective for every patient.
Why this matters for nurses
Stroke and critical-care nurses repeatedly measure blood pressure, assess neurologic status, administer ordered antihypertensives, and escalate deviations after reperfusion. This review matters because it challenges the intuitive assumption that pushing systolic pressure lower than conventional targets necessarily improves recovery.
Bedside takeaway
Be aware that intensive systolic targets below 160 mmHg after stroke reperfusion probably increased mortality without meaningful functional or hemorrhage benefit.
How This Applies in Practice
Use this when: Caring for an adult after thrombolysis or endovascular thrombectomy under an approved post-reperfusion blood-pressure pathway.
On your shift
- Confirm the ordered systolic target and treatment threshold instead of assuming that the most intensive target is preferred.
- Trend blood pressure alongside neurologic assessments and promptly communicate out-of-range values or deterioration through the stroke escalation pathway.
Explain this for my unit
Key takeaways
- The review included nine randomized trials and 4,381 adults after thrombolysis or endovascular thrombectomy.
- Intensive systolic targets below 160 mmHg did not produce a clinically meaningful functional benefit.
- Any intracranial hemorrhage was similar with intensive and conventional management.
- Intensive management probably increased all-cause mortality, with a pooled risk ratio of 1.19.
Practice implications
- Use the prescribed post-reperfusion target and the facility's stroke protocol rather than treating a lower systolic pressure as automatically better. Pair blood-pressure surveillance with neurologic reassessment and promptly communicate out-of-range values or clinical deterioration to the stroke team.
Limitations & cautions
- The intensive targets varied across trials, including thresholds below 120, 140, and 160 mmHg; seven studies involved thrombectomy and two involved thrombolysis. Studies were mainly from upper-middle- and high-income countries, and certainty ranged from high to very low across outcomes.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
The Cochrane database of systematic reviews (PubMed)
The Cochrane database of systematic reviews (PubMed). Blood pressure management in reperfused ischemic stroke.
https://pubmed.ncbi.nlm.nih.gov/42445947/
Professional education only


